Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 59, Issue 5, 2014, Pages 604-607

  Han Geurts, Ingrid J M ^a   Hendrix, Vivian C ^a   De Blaauw, Ivo ^b   Wijnen, Marc H W A ^b   Van Heurn, Ernest L W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Botox; Botulinum toxin injection treatment; Hirschsprung disease; Intraanal sphincter achalasia

Indexed keywords

BOTULINUM TOXIN A; ACETYLCHOLINE RELEASE INHIBITOR;

CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; ENTEROCOLITIS; FATIGUE; FEMALE; FOLLOW UP; HIRSCHSPRUNG DISEASE; HUMAN; INTESTINE OBSTRUCTION; LONG TERM CARE; MALE; MEDICAL RECORD REVIEW; MUSCLE WEAKNESS; OUTCOME ASSESSMENT; PARESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SHORT COURSE THERAPY; TREATMENT DURATION; UNIVERSITY HOSPITAL; WALKING DIFFICULTY; ANAL CANAL; CONSTIPATION; DRUG EFFECTS; HOSPITALIZATION; INFANT; INJECTION; INTESTINAL OBSTRUCTION; NEWBORN; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

ACETYLCHOLINE RELEASE INHIBITORS; ANAL CANAL; BOTULINUM TOXINS, TYPE A; CHILD, PRESCHOOL; CONSTIPATION; ENTEROCOLITIS; HIRSCHSPRUNG DISEASE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS; INTESTINAL OBSTRUCTION; MALE; PARESIS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84925533359     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000483     Document Type: Review

References (19)

1. Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 2008;45:1-14.
2. Georgeson KE, Robertson DJ. Laparoscopic-assisted approaches for the definitive surgery for Hirschsprung's disease. Semin Pediatr Surg 2004;13:256-62.
3. De La Torre L, Langer JC. Transanal endorectal pull-through for Hirschsprung disease: technique, controversies, pearls, pitfalls, and an organized approach to the management of postoperative obstructive symptoms. Semin Pediatr Surg 2010;19:96-106.
4. Rintala RJ, Pakarinen MP. Outcome of anorectal malformations and Hirschsprung's disease beyond childhood. Semin Pediatr Surg 2010;19:160-7.
5. Menezes M, Corbally M, Puri P. Long-term results of bowel function after treatment for Hirschsprung's disease: a 29-year review. Pediatr Surg Int 2006;22:987-90.
6. Chumpitazi BP, Nurko S. Defecation disorders in children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr 2011;53:75-9.
7. Menezes M, Puri P. Long-term outcome of patients with enterocolitis complicating Hirschsprung disease. Pediatr Surg Int 2006;22:316-8.
8. Wildhaber BE, Pakarinen M, Rintala RJ. Posterior myotomy/myectomy for persistent stooling problems in Hirschsprung's disease. J Pediatr Surg 2004;39:920-6.
9. Heikkinen M, Lindahl H, Rintala RJ. Long-term outcome after internal sphincter myectomy for internal sphincter achalasia. Pediatr Surg Int 2005;21:84-7.
10. Chumpitazi BP, Fishman SJ, Nurko S. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter. Am J Gastroenterol 2009;104:976-83.
11. Langer JC, Birnbaum E. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease. J Pediatr Surg 1997;32:1059-62.
12. Langer JC. Persistent obstructive symptoms after surgery for Hirschsprung's disease: development of a diagnostic and therapeutic algorithm. J Pediatr Surg 2004;39:1458-62.
13. Dasgupta R, Langer JC. Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr 2008;46:13-9.
14. Minkes RK, Langer JC. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease. J Pediatr Surg 2000;35:1733-6.
15. Patrus B, Nasr A, Langer JC, et al. Intrasphincteric botulinum toxin decrease the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg 2011;46:184-7.
16. Koivusalu AI, Pakarinen MP, Rintala RJ. Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease. Pediatr Surg Int 2009;25:873-6.
17. Crowner BE, Torres-Russotto D, Carter AR, et al. Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature. Clin Neuropharmacol 2010;33:243-7.
18. Cheng CM, Chen JS, Patel RP. Unlabeled uses of botulinum toxins: a review, part 1. Am J Health Syst Pharm 2006;63:225-32.
19. Jiang DP, Xu CQ, Wu B, et al. Effects of botulinum toxin injection on anal achalasia after pull-through operations for Hirschsprungs disease: a 1-year follow-up study. Int J Colorectal Dis 2009;24:597-8.